You are here Home Resources and guidance Sponsors Apotex Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Cancellation by sponsor (1354) Cancellation or suspension (47) Prescription medicine registration (18) Australian public assessment report (AusPar) (1) Listed medicine compliance report (1) Prescription medicine decision summary (1) Section 14, TGO91 consent (1) Date 2024 (4) 2023 (16) 2022 (159) 2021 (104) 2020 (216) 2019 (124) 2018 (380) 2017 (302) 2016 (34) 2015 (52) 2014 (32) Search Sponsor content1423 result(s) found, displaying 1421 to 1423 TERRY WHITE CHEMISTS ESCITALOPRAM escitalopram (as oxalate) 10 mg tablet blister pack Cancelled under s30(1)(c) 9 July 2014 Cancellation by sponsor Requested by Apotex Pty Ltd APO-ESCITALOPRAM escitalopram (as oxalate) 10 mg tablet blister pack Cancelled under s30(1)(c) 9 July 2014 Cancellation by sponsor Requested by Apotex Pty Ltd APO-ESCITALOPRAM escitalopram (as oxalate) 20 mg tablet blister pack Cancelled under s30(1)(c) 9 July 2014 Cancellation by sponsor Requested by Apotex Pty Ltd Pages First page « First Previous page ‹ Previous … Page 135 Page 136 Page 137 Page 138 Page 139 Page 140 Page 141 Page 142 Current page 143
TERRY WHITE CHEMISTS ESCITALOPRAM escitalopram (as oxalate) 10 mg tablet blister pack Cancelled under s30(1)(c) 9 July 2014 Cancellation by sponsor Requested by Apotex Pty Ltd
APO-ESCITALOPRAM escitalopram (as oxalate) 10 mg tablet blister pack Cancelled under s30(1)(c) 9 July 2014 Cancellation by sponsor Requested by Apotex Pty Ltd
APO-ESCITALOPRAM escitalopram (as oxalate) 20 mg tablet blister pack Cancelled under s30(1)(c) 9 July 2014 Cancellation by sponsor Requested by Apotex Pty Ltd